Home › Funds › Saturn V Capital Management LP › MSLE
Saturn V Capital Management LP position in MSLE
SATELLOS BIOSCIENCE INC · Health Care
Saturn V Capital Management LP reported holding 516,800 shares of MSLE (SATELLOS BIOSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.64% of its reported portfolio and ranking #24 among its reported holdings. Saturn V Capital Management LP has disclosed MSLE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Saturn V Capital Management LP's MSLE position evolved
Saturn V Capital Management LP first disclosed a stake in MSLE in Q1 2026 at 350,000 shares (US$2.0M). The position peaked in Q3 2026 at 516,800 shares, worth US$4.4M. Across 3 filings, Saturn V Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 516,800 shares valued at US$4.4M — an increase of 166,800 shares quarter over quarter.. Notable position changes include a 48% increase in Q3 2026 (shares fell 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 350.00K | $1.97M | New |
| Q2 2026 | 350.00K | $2.72M | Hold |
| Q3 2026 | 516.80K | $4.39M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MSLE and 13F data
MSLE (SATELLOS BIOSCIENCE INC) is a Health Care company. 31 other funds we track also report a position in MSLE — the largest reported positions include Vivo Capital, LLC (US$6.9M), SPHERA FUNDS MANAGEMENT LTD. (US$5.1M), Stonepine Capital Management, LLC (US$3.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MSLE
- Vivo Capital, LLC 813.67K sh · $6.92M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 652.59K sh · $5.07M · Q2 2026
- Stonepine Capital Management, LLC 455.06K sh · $3.87M · Q3 2026
- Avidity Partners Management LP 387.77K sh · $3.01M · Q2 2026
- CRCM LP 68.06K sh · $578.51K · Q3 2026
- Empery Asset Management, LP 58.00K sh · $493.00K · Q3 2026
More on Saturn V Capital Management LP
FAQ
How long has Saturn V Capital Management LP held MSLE?
Saturn V Capital Management LP has disclosed MSLE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Saturn V Capital Management LP's current position in MSLE?
As of Q3 2026, Saturn V Capital Management LP holds 516.80K shares of MSLE (SATELLOS BIOSCIENCE INC), valued at $4.39M, representing 0.64% of its reported portfolio and ranking #24.
Has Saturn V Capital Management LP been buying or selling MSLE?
In the latest 13F filing (Q3 2026), Saturn V Capital Management LP increased its position in MSLE. The position peaked in Q3 2026 at 516.80K shares.
Which other funds hold MSLE?
Other major institutional holders of MSLE include Vivo Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., Stonepine Capital Management, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.